Akari Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKTX and other ETFs, options, and stocks.

About AKTX

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor.

CEO

Abizer Gaslightwala

CEOAbizer Gaslightwala

Employees

Employees9

Headquarters

Tampa, Florida

HeadquartersTampa, Florida

Founded

2004

Founded2004

Employees

Employees9

AKTX Key Statistics

Market cap

8.76M

Market cap8.76M

Price-Earnings ratio

-0.04

Price-Earnings ratio-0.04

Dividend yield

—

Dividend yield—

Average volume

2.68M

Average volume2.68M

High today

$0.27

High today$0.27

Low today

$0.23

Low today$0.23

Open price

$0.259

Open price$0.259

Volume

922.48K

Volume922.48K

52 Week high

$1.73

52 Week high$1.73

52 Week low

$0.2178

52 Week low$0.2178

Akari Therapeutics

Why Robinhood?

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. Show more

AKTX Key Statistics

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor.